Acute and Long-term Results with the 3 Generation Visually Guided Laser Balloon Ablation System for Pv Isolation

Overview

Journal J Interv Card Electrophysiol

Publisher Springer

Date 2023 Feb 22

PMID 36805921

Authors

Moritoshi Funasako

Jan Petru

Pavel Hala

Marek Janotka

Jan Skoda

Milan Chovanec

Lucie Sediva

Vivek Y Reddy

Petr Neuzil

Affiliations

Soon will be listed here.

Abstract

Background: Visually guided laser balloon ablation is known as an effective pulmonary vein (PV) isolation device. The third-generation laser balloon ablation system (X3) equipped with compliant balloon and an automated motor-driven laser output mechanism, namely RAPID mode, has been clinically proven for PV isolation.

Methods: PV isolation with X3 was performed in all the patients with paroxysmal and early-stage persistent atrial fibrillation (AF). Acute data for PV isolation and clinical outcomes including supraventricular tachyarrhythmia (SVT: AF, atrial flutter, or atrial tachycardia)-free survival rate beyond 1 year were analyzed.

Results: A total of 110 patients (62 ± 13 years old, 80% of paroxysmal AF) were treated with X3. RAPID mode with was utilized to achieve PV isolation in all cases. In combination with RAPID mode and spot mode laser ablation, 91.1% (380/417) of veins were isolated on the first circumferential lesion set and did not require touch-up ablation and during the index procedure 100% of attempted veins were isolated. The mean procedure time was 77.0 ± 22.7 min and LA dwell time was 61.9 ± 22.0 min. Total duration of laser application was 5.1 ± 2.3 min per vein. At 1 year, SVT-free survival rate was 93.7% in paroxysmal AF patients, and 81.1% in persistent AF patients.

Conclusions: A novel continuous automatic laser balloon ablation system was proved to be safe and effective for both paroxysmal and persistent AF patients. The clinical result demonstrated that PV isolation with X3 could achieve a high SVT-free survival rate.

Citing Articles

Contemporary Trends in Pulsed Field Ablation for Cardiac Arrhythmias.

Yavin H, Prasad M, Gordon J, Aksu T, Huang H J Cardiovasc Dev Dis. 2025; 12(1).

PMID: 39852288 PMC: 11766314. DOI: 10.3390/jcdd12010010.

Current Balloon Devices for Ablation of Atrial Fibrillation.

Nakahara S, Hori Y, Fukuda R, Sato H, Aoki H, Kondo Y Rev Cardiovasc Med. 2024; 25(1):34.

PMID: 39077656 PMC: 11262367. DOI: 10.31083/j.rcm2501034.

References

Sediva L, Petru J, Skoda J, Janotka M, Chovanec M, Reddy V . Visually guided laser ablation: a single-centre long-term experience. Europace. 2014; 16(12):1746-51. DOI: 10.1093/europace/euu168. View

Molina-Ramos A, Ruiz-Salas A, Medina-Palomo C, Pavon-Moron F, Rodriguez-Capitan J, Gutierrez-Bedmar M . Reablation in Atrial Fibrillation Recurrence and Pulmonary Vein Reconnection: Cryoballoon versus Radiofrequency as Index Ablation Procedures. J Clin Med. 2022; 11(19). PMC: 9573280. DOI: 10.3390/jcm11195862. View

Verma A, Jiang C, Betts T, Chen J, Deisenhofer I, Mantovan R . Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015; 372(19):1812-22. DOI: 10.1056/NEJMoa1408288. View

Dukkipati S, Neuzil P, Skoda J, Petru J, dAvila A, Doshi S . Visual balloon-guided point-by-point ablation: reliable, reproducible, and persistent pulmonary vein isolation. Circ Arrhythm Electrophysiol. 2010; 3(3):266-73. DOI: 10.1161/CIRCEP.109.933283. View

Andrade J, Khairy P, Macle L, Packer D, Lehmann J, Holcomb R . Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial. Circ Arrhythm Electrophysiol. 2014; 7(1):69-75. DOI: 10.1161/CIRCEP.113.000586. View

Yamaguchi M, Miyazaki S, Kajiyama T, Hada M, Nakamura H, Hachiya H . Pulmonary vein isolation in patients with a left common pulmonary vein: Comparison between second-generation cryoballoon and radiofrequency ablation. J Cardiol. 2018; 73(4):292-298. DOI: 10.1016/j.jjcc.2018.12.004. View

January C, Samuel Wann L, Alpert J, Calkins H, Cigarroa J, Cleveland Jr J . 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014; 130(23):e199-267. PMC: 4676081. DOI: 10.1161/CIR.0000000000000041. View

Schmidt B, Petru J, Chun K, Sediva L, Bordignon S, Chen S . Pivotal Study of a Novel Motor-Driven Endoscopic Ablation System. Circ Arrhythm Electrophysiol. 2021; 14(3):e009544. DOI: 10.1161/CIRCEP.120.009544. View

January C, Samuel Wann L, Calkins H, Chen L, Cigarroa J, Cleveland Jr J . 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the.... Circulation. 2019; 140(2):e125-e151. DOI: 10.1161/CIR.0000000000000665. View

10.

Lennon S, Mannion J, Keelan E, OBrien J, Jauvert G, Gul E . Ablation Index Outcome in Redo Persistent Atrial Fibrillation Ablation: Results of a Short-Term Study. Cardiol Res. 2022; 13(2):97-103. PMC: 8993438. DOI: 10.14740/cr1337. View

11.

Heeger C, Tiemeyer C, Phan H, Meyer-Saraei R, Fink T, Sciacca V . Rapid pulmonary vein isolation utilizing the third-generation laserballoon - The PhoeniX registry. Int J Cardiol Heart Vasc. 2020; 29:100576. PMC: 7334810. DOI: 10.1016/j.ijcha.2020.100576. View

12.

Reddy V, Neuzil P, Themistoclakis S, Danik S, Bonso A, Rossillo A . Visually-guided balloon catheter ablation of atrial fibrillation: experimental feasibility and first-in-human multicenter clinical outcome. Circulation. 2009; 120(1):12-20. DOI: 10.1161/CIRCULATIONAHA.108.840587. View

13.

Morillo C, Verma A, Connolly S, Kuck K, Nair G, Champagne J . Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014; 311(7):692-700. DOI: 10.1001/jama.2014.467. View

14.

Heeger C, Phan H, Meyer-Saraei R, Fink T, Sciacca V, Liosis S . Second-Generation Visually Guided Laser Balloon Ablation System for Pulmonary Vein Isolation: Learning Curve, Safety and Efficacy　- The MERLIN Registry. Circ J. 2019; 83(12):2443-2451. DOI: 10.1253/circj.CJ-19-0766. View

15.

Wazni O, Dandamudi G, Sood N, Hoyt R, Tyler J, Durrani S . Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation. N Engl J Med. 2020; 384(4):316-324. DOI: 10.1056/NEJMoa2029554. View

16.

Miyazaki S, Horie T, Hachiya H, Hasegawa K, Kajiyama T, Watanabe T . The mechanisms of recurrent atrial arrhythmias after second-generation cryoballoon ablation. Am Heart J. 2020; 221:29-38. DOI: 10.1016/j.ahj.2019.12.002. View

17.

Chun J, Bordignon S, Last J, Mayer L, Tohoku S, Zanchi S . Cryoballoon Versus Laserballoon: Insights From the First Prospective Randomized Balloon Trial in Catheter Ablation of Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2021; 14(2):e009294. DOI: 10.1161/CIRCEP.120.009294. View

18.

Fink T, Schluter M, Heeger C, Lemes C, Maurer T, Reissmann B . Stand-Alone Pulmonary Vein Isolation Versus Pulmonary Vein Isolation With Additional Substrate Modification as Index Ablation Procedures in Patients With Persistent and Long-Standing Persistent Atrial Fibrillation: The Randomized Alster-Lost-AF.... Circ Arrhythm Electrophysiol. 2017; 10(7). DOI: 10.1161/CIRCEP.117.005114. View

19.

Chun K, Perrotta L, Bordignon S, Khalil J, Dugo D, Konstantinou A . Complications in Catheter Ablation of Atrial Fibrillation in 3,000 Consecutive Procedures: Balloon Versus Radiofrequency Current Ablation. JACC Clin Electrophysiol. 2018; 3(2):154-161. DOI: 10.1016/j.jacep.2016.07.002. View

20.

Heeger C, Pott A, Sohns C, Riesinger L, Sommer P, Gasperetti A . Novel cryoballoon ablation system for pulmonary vein isolation: multicenter assessment of efficacy and safety-ANTARCTICA study. Europace. 2022; 24(12):1917-1925. PMC: 9733956. DOI: 10.1093/europace/euac148. View